Llwytho...
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial
IMPORTANCE: Post-hoc analyses from DRCR.net randomized trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME) might influence interpretation of study results. OBJECTIVE: To provide additional post-hoc clinically relevant outcomes comparing three anti-VEGF agents f...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | JAMA Ophthalmol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567802/ https://ncbi.nlm.nih.gov/pubmed/27711918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2016.3698 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|